Earnings calendar/KROS
Keros Therapeutics, Inc. (KROS)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Latest EPS YoY
-90.8%
vs 2025-08-06
Latest revenue YoY
0.0%
How results look so far
Trailing revenue (avg 4Q)
$8.3M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS miss
EPS actual / est
$-1.45 / $-1.34
-8.2%
Revenue actual / est
$18.2M / $807,143
+2150.9%
Result
Below target
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/3/2026 | $-1.34 | $-1.45 | -8.2% | $807,143 | $18.2M | +2150.9% |
| 5/14/2026 | $-0.92 | $-1.21 | -31.5% | $1.9M | $367,000 | -81.0% |
| 5/13/2026upcoming | $-0.92 | Pending | — | $1.9M | Pending | — |
| 5/12/2026upcoming | $-0.92 | Pending | — | $1.9M | Pending | — |
| 5/11/2026upcoming | $-1.02 | Pending | — | $1.9M | Pending | — |
| 5/5/2026upcoming | $-1.09 | Pending | — | $1.9M | Pending | — |
| 3/4/2026 | $-0.49 | $-0.86 | -75.5% | $3.7M | $385,000 | -89.5% |
| 2/25/2026upcoming | $-0.49 | Pending | — | $3.7M | Pending | — |
| 11/5/2025 | $-1.11 | $-0.18 | +83.8% | $3.7M | $14.3M | +289.4% |
| 8/6/2025 | $-1.14 | $-0.76 | +33.3% | $3.2M | $18.2M | +465.9% |
| 5/6/2025 | $-0.01 | $3.62 | +36300.0% | $56.6M | $211.2M | +272.9% |
| 2/26/2025 | $-1.36 | $-1.14 | +16.2% | $22.2M | $3.0M | -86.3% |
| 11/6/2024 | $-1.26 | $-1.41 | -11.9% | $2.3M | $388,000 | -83.2% |
| 8/7/2024 | $-1.23 | $-1.25 | -1.6% | — | $37,000 | — |
| 5/8/2024 | $-1.31 | $-1.21 | +7.6% | — | $83,000 | — |
| 2/28/2024 | $-1.38 | $-1.34 | +2.9% | — | $143,000 | — |
| 11/6/2023 | $-1.34 | $-1.33 | +0.7% | — | $8,000 | — |
| 8/7/2023 | $-1.34 | $-1.27 | +5.2% | $160,000 | Pending | — |
| 5/4/2023 | $-1.13 | $-1.26 | -11.5% | $220,000 | Pending | — |
| 3/3/2023 | $-1.12 | $-1.09 | +2.7% | $1.2M | Pending | — |
Need KROS data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.